Digital x-ray and bone densitometry developer Schick Technologies of Long Island City, NY, is facing several class-action complaints filed by its shareholders, according to Eli Schick, director of investor relations. The complaints, brought this month by
Digital x-ray and bone densitometry developer Schick Technologies of Long Island City, NY, is facing several class-action complaints filed by its shareholders, according to Eli Schick, director of investor relations. The complaints, brought this month by several law firms, claim that Schick knowingly misstated its financial condition before announcing on Dec. 10 that it would take a one-time charge of $5 million against earnings for its third quarter 1998, ending December (SCAN 1/14/99).
In more positive Schick news, the company received a patent for its accuDEXA bone densitometer on Jan. 8. The Food and Drug Administration cleared the unit in December 1997 (SCAN 1/21/98), and Schick has sold about 2500 of the densitometers. AccuDEXA is priced under $13,000.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
2 Commerce Drive
Cranbury, NJ 08512